Form 8-K - Current report:
SEC Accession No. 0001558370-25-003116
Filing Date
2025-03-17
Accepted
2025-03-17 16:05:11
Documents
14
Period of Report
2025-03-17
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K akya-20250317x8k.htm   iXBRL 8-K 43872
2 EX-99.1 akya-20250317xex99d1.htm EX-99.1 301553
  Complete submission text file 0001558370-25-003116.txt   489059

Data Files

Seq Description Document Type Size
3 EX-101.SCH akya-20250317.xsd EX-101.SCH 3408
4 EX-101.LAB akya-20250317_lab.xml EX-101.LAB 16579
5 EX-101.PRE akya-20250317_pre.xml EX-101.PRE 10455
16 EXTRACTED XBRL INSTANCE DOCUMENT akya-20250317x8k_htm.xml XML 5042
Mailing Address 100 CAMPUS DRIVE 6TH FLOOR MARLBOROUGH MA 01762
Business Address 100 CAMPUS DRIVE 6TH FLOOR MARLBOROUGH MA 01762 855.896.8401
Akoya Biosciences, Inc. (Filer) CIK: 0001711933 (see all company filings)

EIN.: 475586242 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40344 | Film No.: 25744375
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)